Startups · AI

Staff Software Engineer, Infrastructure

Multiply Labs · San Francisco · On-site

← All jobs
About Multiply Labs

Backed by Y Combinator and Lux.

About the role

Our robots run in customer cleanrooms, on compute we deploy and maintain, under GMP rules that require every software change to be traceable. We're hiring a Staff Software Engineer to be the first dedicated owner of infrastructure across our software org, from the cloud services behind our product to the software running on robots at customer sites. This is a design role first: we want someone who has built systems that had to work under real constraints, and who prefers the simplest design that will hold up. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • 8+ years building software systems, with a substantial part of that owning infrastructure or deployment
  • Designed and built a non-trivial system yourself (a deploy or rollout system, a device agent, an orchestrator, a provisioning pipeline) and can explain its tradeoffs, failure modes, and what you would change
  • Experience shipping software to computers you don't fully control: robots, vehicles, IoT or edge devices, or on-prem installs at customer sites
  • Have taken a company through SOC 2 or ISO 27001, or owned a major part of an audit
  • Strong in Python, with deep Linux and networking skills: systemd, packaging, and debugging a machine you can only reach remotely
  • Solid AWS and infrastructure-as-code experience (Terraform or CloudFormation), and enough Docker and Kubernetes to choose when not to use them
More about this role

Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more.

Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high—often $500K–$2M per patient—limiting access to only a small fraction of those who need them.

As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable.

We believe the future of biomanufacturing is robotic—closed, automated, and scalable—ensuring critical therapeutics are accessible to every patient who needs them.

We don’t just build robots—we’re building the essential infrastructure for next generation biologics. Our technology enables biopharma companies to scale production without redesigning their science, reducing regulatory hurdles and lowering costs so these treatments can reach more patients.

The Mission: Build the world’s best robots to make life-saving therapies accessible to all.

The...

Read the full posting on Multiply Labs's site ↗

System Software

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.